3,027
Views
28
CrossRef citations to date
0
Altmetric
Articles

Parent–child interaction therapy (PCIT) in young children with autism spectrum disorder

, PhD, , PhD, , MSW, , MA, , MEd, LBS & , PhD
Pages 201-220 | Received 10 Dec 2018, Accepted 25 Mar 2019, Published online: 12 Sep 2019
 

Abstract

Parent–child interaction therapy (PCIT) is an evidence-based treatment for typically developing children with disruptive behavior. We conducted a randomized-controlled trial of PCIT versus wait-list control (WLC) with 23 children with ASD (3–7 years) and disruptive behavior. Over 16 treatment sessions, PCIT significantly predicted reductions in disruptive behavior over WLC and explained a significant variation in scores on the ECBI Intensity subscale. Additionally, parent skills improved significantly compared to WLC. However, no statistically significant group differences were found on child compliance rates, autism severity, or parental stress. Results support PCIT as an evidence-based treatment for disruptive behavior in ASD.

    Highlights

  • Parent skills were significantly improved for those receiving PCIT

  • Intensity of disruptive behaviors decreased significantly for those receiving PCIT

  • Parental stress and autism severity did not significantly decrease with PCIT

Acknowledgements

The authors wish to thank the many families who participated in this research. In addition, we would like to recognize Maria Tina Benno, BA, Ryan Young, BA and Oliver Johnson, BA, who conducted the DPICs coding; Allison Cotter, who conducted session fidelity; Catherine Stahler, PhD, Danielle Saad, LCSW, Sara Green, LCSW and Lindsey Rose, LCSW, who assisted in conducting PCIT treatment sessions; and Ben Wells, MS and Victoria Bocast, BS, for their assistance with the database and statistical analysis.

Additional information

Funding

This study was funded by Autism Speaks (#8807). Dr. Handen received support from the National Institute on Aging (R01AG031110-03A1; 1R01AG051406-01), the National Institute of Mental Health (1R01MH079082-01A2), Autism Speaks, Eli Lilly, and Roche. The other authors have no conflicts of interest.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 53.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 527.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.